Licensed to practice in Maryland and accepts 20 insurances. Specializes in Medication Management and 3 more.
I am an Adult Psychiatric Nurse Practitioner. When you and your therapist feel that your therapy might benefit from a course of mental health medication, I can assist with the medication management. I use prescription drugs, over-the-counter supplements, and specialized lab tests to help with choosing the best medication for a specific patient. Note that I do not at this time offer assistance with opioid or benzodiazepine prescriptions, substance use disorders, care of persons with intellectual or developmental disorders, or medication management during pregnancy. My secure telehealth software is ZOOM, and I will send a ZOOM link after an appointment is confirmed. The initial appointment is about 60 minutes but follow-up meetings are only about 20-30 minutes. I call each person who makes an online appointment for an initial consultation to discuss what services are needed; after that call and after obtaining some additional information, I will confirm the initial appointment. Follow-up appointments, cancellations, postponements, etc., are made directly with me, not online.
We will review your physical and mental health histories. I will conduct a psychiatric evaluation and make a psychiatric diagnosis. I will suggest interventions such as medications or non-pharmaceutical treatments. I will provide a general timeline for treatments.
Knowledge of mental health medications, both prescription and over the counter.
Independent adults age 21 or older with Depression, Anxiety, Bipolar Disorder Type II, ADD/ADHD
Other specialties
I identify as
Cash - $140 per session
Aetna
Aetna - Allied Benefits
Aetna - ASR Health Benefits
Aetna - Luminare
Aetna - Moda
Aetna - WebTPA
Aetna – HealthEZ
Amerihealth Administrators
Anthem
Arlo
Blue Cross Blue Shield
CareFirst
Centivo
Cigna
Cigna - HealthEZ
Evernorth
GTEB
Independence Administrators
Independence Blue Cross
Tufts Health/Cigna
Psychoeducation
Detailed information on medications under discussion, i.e., their costs with and without insurance, availability related to shortages and supply chain issues, their possible side effects, their interactions with foods and other drugs, the statistical likelihood of a good response, likely disease progression if no meds are used, and alternatives to pharmacological management.